Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-21-006093
Filing Date
2021-10-04
Accepted
2021-10-04 15:56:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8979895_13g.htm SC 13G 122529
  Complete submission text file 0000919574-21-006093.txt   124112
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Subject) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91228 | Film No.: 211302551
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1055B POWERS PLACE FL2 ALPHARETTA GA 30009
Business Address 1055B POWERS PLACE FL2 ALPHARETTA GA 30009 9012923974
Avego Management LLC (Filed by) CIK: 0001886177 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G